Skip to main content
UniHealth

Doctor search

Shiva R Singhal, MD

Hematology/Oncology · Mountain View

NPI 1942456389

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
32
8 carriers
Office
1

Offices

1 location · El Camino Health Medical Network LLC · 202 clinicians in this group

Looking this up.

Hospitals listed: Adventist Health Sonora · El Camino Health · Stanford Health Care. That is not proof they admit you there this week.

Plans that list them

32 plans · 8 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Singhal’s office at (650) 988-8338 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

32 of 32 plans

Plans whose provider directory lists this clinician
Alignment Health Advantage PPO (PPO)Alignment Health PlanListedOct 3, 2026
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Silicon (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health smartHMO (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health the ONE (HMO)Alignment Health PlanListedOct 3, 2026
Anthem Full Dual Advantage Aligned (HMO D-SNP)Anthem Blue CrossListedOct 3, 2026
Anthem Medicare Advantage (HMO-POS)Anthem Blue CrossListedOct 3, 2026
Anthem Prime (HMO-POS)Anthem Blue Cross Partnership PlanListedOct 3, 2026
Astiva Health C-SNP WOW - NorCal (HMO C-SNP)Astiva HealthListedSep 27, 2026
Astiva Health Premier Plan - NorCal (HMO)Astiva HealthListedSep 27, 2026
Astiva Health Savings Plan - NorCal (HMO)Astiva HealthListedSep 27, 2026
Blue Shield Inspire (HMO)Blue Shield of CaliforniaListedAug 26, 2026
Central Health Classic Care Plan III (HMO)Central Health Medicare PlanListedAug 15, 2026
Central Health Dual Access Plan (HMO D-SNP)Central Health Medicare PlanListedAug 15, 2026
Central Health Embrace Care Plan (HMO C-SNP)Central Health Medicare PlanListed, may be out of dateSep 15, 2025
Central Health Embrace Choice Plan (HMO C-SNP)Central Health Medicare PlanListedAug 15, 2026
Central Health Valor Care Plan (HMO)Central Health Medicare PlanListedAug 15, 2026
Imperial Courage Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Dynamic Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Senior Value (HMO C-SNP)Imperial Health Plan of California, Inc.ListedSep 1, 2026
SCAN Balance (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
SCAN Classic (HMO)SCAN Health PlanListedOct 3, 2026
SCAN MyChoice (HMO)SCAN Health PlanListedOct 3, 2026
SCAN Strive (HMO C-SNP)SCAN Health PlanListedOct 3, 2026

California Medical Board record

Licence A126309 · Current

Licensed to practise in California · since 2013 · expires 2026-12-31 · University of Delhi, Lady Hardinge Medical College.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

3 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Adventist Health SonoraSonora, CAAcute Care Hospital · Voluntary non-profit - Church · No emergency department · Birthing-friendlyPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 3 of 5 · 64% would definitely recommend it
    Overall rating: 3 of 5 starsWorse than the national rate — Postoperative wound dehiscence rate: 3.5 (2.04 to 4.96) · 288 cases, Jul 2022 – Jun 2024Worse than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 1.3 (1 to 1.6) · 1,004 cases, Jan 2024 – Dec 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.185, Oct 2024 – Sep 2025
  • El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend it
    Overall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Adventist Health Sonora

Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 0 better, 4 the same, 0 worse of 4 measures. Readmissions: 1 better, 7 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Adventist Health Sonora
Postoperative wound dehiscence rateComplications and deaths3.5 (2.04 to 4.96) · 288 casesWorseJul 2022 – Jun 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1.3 (1 to 1.6) · 1,004 casesWorseJan 2024 – Dec 2024
Clostridium Difficile (C.Diff)Infections0.185BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.15 (0.14 to 2.16) · 582 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.87 (0.5 to 1.24)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths182.91 (123.44 to 242.37) · 38 casesNo differentJul 2022 – Jun 2024
Death rate for COPD patientsComplications and deaths7.9 · 118 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9 · 125 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths11.7 · 236 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths15 · 433 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths12 · 72 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.9 · 1,364 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.18 (0 to 0.39) · 3,671 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.07 to 0.48) · 3,602 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.41 (1.24 to 5.59) · 803 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.57 (0 to 3.24) · 310 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.59 (0.98 to 4.2) · 754 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths7.97 (0 to 16.16) · 306 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.72 (1.85 to 9.58) · 277 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.23 (0 to 1.06) · 2,750 casesNo differentJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.614No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.6 · 105 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits19.6 · 209 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits12.6 · 119 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-23.8 · 255 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-13.4 · 455 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.3 · 381 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6 (4.3 to 8.1) · 328 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits11.7 (9.1 to 14.7) · 328 casesNo differentJan 2024 – Dec 2024
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.3 · 106 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.8 (10 to 16.3) · 1,835 casesNo differentJan 2022 – Dec 2024

What patients said (326 patients answered, 21% of those asked)

Patient survey stars by topic at Adventist Health Sonora
Cleanliness3
Nurse communication4
Doctor communication3
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness2
Recommend hospital3
Share of patients giving the best answer at Adventist Health Sonora
Room was "always" clean69%
Nurses "always" communicated well80%
Doctors "always" communicated well77%
Staff "always" explained61%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge86%
Doctors "always" explained things so they could understand72%
Doctors "always" listened carefully74%
Doctors "always" treated them with courtesy and respect85%
Patients who gave a rating of "9" or "10" (high)64%
Staff "always" explained new medications73%
Nurses "always" explained things so they could understand75%
Nurses "always" listened carefully76%
Nurses "always" treated them with courtesy and respect89%
"Always" quiet at night44%
"YES", patients would definitely recommend the hospital64%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms93%
See every measure and the patient survey for El Camino Health

Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at El Camino Health
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.291BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.393BetterOct 2024 – Sep 2025
MRSA BacteremiaInfections0BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.96 (0.12 to 1.79) · 2,340 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.02 (0.76 to 1.28)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths167.38 (125.03 to 209.73) · 96 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.6 · 68 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.1 · 185 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths11.8 · 200 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths8.9 · 814 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths13 · 842 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths9.6 · 361 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.6 · 4,633 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.34) · 11,474 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.27 (0.1 to 0.45) · 11,626 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.14 (1.39 to 4.9) · 2,814 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths2 (0.61 to 3.39) · 1,327 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.11 (0.8 to 3.43) · 2,641 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths9.39 (4.18 to 14.6) · 1,287 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths6.57 (3.47 to 9.68) · 1,308 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths2.14 (0.71 to 3.57) · 827 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.6 (0.05 to 1.15) · 9,460 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4.5 · 122 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.993No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.706No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.376No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits15.5 · 218 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits19.5 · 962 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits3.8 · 200 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-17 · 922 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits18.6 · 860 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits18.7 · 827 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.1 (4.5 to 8.2) · 313 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits13.4 (10.6 to 16.5) · 313 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits6.1 · 144 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20.7 · 237 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.8 (10 to 16.1) · 1,639 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.9 (0.8 to 1.1) · 1,619 casesNo differentJan 2024 – Dec 2024

What patients said (1,535 patients answered, 22% of those asked)

Patient survey stars by topic at El Camino Health
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information3
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at El Camino Health
Room was "always" clean75%
Nurses "always" communicated well79%
Doctors "always" communicated well81%
Staff "always" explained61%
Yes, staff "did" give patients this information86%
Yes, staff "did" give patients information about help after discharge86%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)76%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand75%
Nurses "always" listened carefully76%
Nurses "always" treated them with courtesy and respect87%
"Always" quiet at night47%
"YES", patients would definitely recommend the hospital80%
Staff "always" explained possible side effects46%
Yes, staff "did" give patients information about possible symptoms86%
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$230,881

Medicare paid this office $230,881 for 388 people. Most of that is long return visits and Botox.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Long return visit (40+ min)322$131,261$122
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes74$57,798$107
Initial hospital care with moderate level of medical decision making at least 75 minutes72$13,254$143
Telephone medical discussion with physician, 21-30 minutes69$13,058$115
New patient visit (60+ min)51$8,483$166

Who their Medicare patients are

388 Original Medicare patients in 2024. Average age 77 · Under 65 4% · 85 and older 23% · Women 55% · Also on Medicaid 16% · Health risk score 1.88. At or below the middle of the specialty; the typical hematology-oncology clinician is at 2.04.

Conditions among them: High blood pressure 75% · Coronary heart disease 35% · Cancer 35% · Diabetes 34% · Chronic kidney disease 32% · Atrial fibrillation 27% · Heart failure 26% · Depression 20% · COPD 15% · Dementia 12% · Stroke 11%.

The office billed $1,091,680, Medicare allowed $307,646 and paid $230,881; for 1,961 services of 14 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20243881,961771.88$1,091,680$230,881
20233852,335772.16$1,265,724$274,902
20223462,391771.94$1,237,256$276,366
20213162,599772.06$1,250,317$303,079
20202421,896772.24$866,129$180,649
20192441,474781.94$689,861$147,981
20181932742.45$13,967$3,646
20151623702.31$6,918$1,714
2014105235731.84$79,668$22,348

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 7 services

Original Medicare services billed in 2023
Long return visit (40+ min)282$141,035$122
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes105$61,407$108
Telephone medical discussion with physician, 21-30 minutes119$25,114$116
Initial hospital care with moderate level of medical decision making at least 75 minutes95$21,170$153
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes28$9,873$73
New patient visit (60+ min)46$7,531$164
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes17$2,384$119

2022: 7 services

Original Medicare services billed in 2022
Long return visit (40+ min)260$127,916$124
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes107$86,825$95
Initial hospital care with moderate level of medical decision making at least 75 minutes89$26,289$175
Telephone medical discussion with physician, 21-30 minutes86$17,639$117
New patient visit (60+ min)49$7,960$162
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes19$2,512$126
Hospital discharge day management, more than 30 minutes15$1,881$99

2021: 10 services

Original Medicare services billed in 2021
Long return visit (40+ min)224$134,940$131
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes125$91,182$92
Initial hospital care with moderate level of medical decision making at least 75 minutes103$33,610$179
Telephone medical discussion with physician, 21-30 minutes58$14,967$125
Return visit (30+ min)72$7,819$74
Hospital discharge day management, more than 30 minutes22$5,537$101
New patient visit (60+ min)25$4,122$165
Long return visit (40+ min)12$3,736$129
New patient visit (45+ min)29$3,563$123
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes11$1,765$126

2020: 10 services

Original Medicare services billed in 2020
Long return visit (40+ min)177$78,450$90
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes87$53,445$91
Initial hospital care with moderate level of medical decision making at least 75 minutes72$21,831$172
Return visit (30+ min)64$9,211$69
Telephone medical discussion with physician, 21-30 minutes34$5,716$97
New patient visit (60+ min)21$2,876$137
Hospital discharge day management, more than 30 minutes12$2,098$95
Long return visit (40+ min)15$2,083$104
New patient visit (45+ min)18$2,028$113
Telephone medical discussion with physician, 11-20 minutes14$893$64

2019: 6 services

Original Medicare services billed in 2019
Long return visit (40+ min)162$73,935$94
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes96$39,497$89
Initial hospital care with moderate level of medical decision making at least 75 minutes70$21,526$172
New patient visit (60+ min)53$7,569$143
Hospital discharge day management, more than 30 minutes11$1,126$94
Biopsy and aspiration of bone marrow sample for diagnosis11$760$69

2018: 1 service

Original Medicare services billed in 2018
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes17$1,837$84

2015: 1 service

Original Medicare services billed in 2015
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes14$1,322$73

2014: 2 services

Original Medicare services billed in 2014
Long return visit (40+ min)90$17,538$89
New patient visit (60+ min)30$4,078$136

Medicaid work

$458 in 2024

Medicaid paid $458 for 52 billed services this clinician did in 2024, up to 14 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Long return visit (40+ min)52$458
Medicaid work by year
202452114$458
202318114$0
2018206625$6,911
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Long return visit (40+ min)18$0

2018

Largest Medicaid services in 2018
Long return visit (40+ min)107$5,639
Return visit (30+ min)30$1,168
COMPREHENSIVE METABOLIC PANEL19$60
Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count19$44
COLLECTION VENOUS BLOOD VENIPUNCTURE14$0
Hospital outpatient clinic visit for assessment and management of a patient17$0

Drugs they prescribed that Part D paid

$2,938,274

Pharmacies billed $2,938,274 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 6% of their Part D prescriptions (63 of 1,025) in 2024. Above the middle of the specialty; the typical hematology-oncology clinician is at 5%.

708 generic and fewer than 11 brand-name prescriptions · $2,938,274 in drug cost · 19 antibiotic prescriptions to 12 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Xtandi36$514,720$14,298
Calquence26$425,150$16,352
Tagrisso24$421,028$17,543
Tibsovo12$397,453$33,121
Lenvima11$270,732$24,612
See all 36 drugs
Every Part D drug this clinician prescribed
Xtandi36$514,720$14,298
Calquence26$425,150$16,352
Tagrisso24$421,028$17,543
Tibsovo12$397,453$33,121
Lenvima11$270,732$24,612
Jakafi15$263,676$17,578
Revlimid15$184,149$12,277
Eliquis102$77,730$762
Fulphila12$24,268$2,022
Xarelto24$23,366$974
Abiraterone Acetate12$14,531$1,211
Imatinib Mesylate19$14,156$745
Enoxaparin18$4,908$273
Anastrozole87$1,829$21
Hydroxyurea55$1,425$26
Tamoxifen Citrate18$851$47
Acyclovir18$590$33
Pantoprazole15$392$26
Letrozole27$378$14
Dexamethasone18$369$21
Ondansetron Odt16$343$21
Levothyroxine18$331$18
Sertraline12$311$26
Venlafaxine Hcl Er25$266$11
Oxycodone20$264$13
Hydrocodone-Acetaminophen18$262$15
Warfarin17$243$14
Prednisone28$188$7
Gabapentin11$152$14
Trazodone11$152$14
Ropinirole14$138$10
Ondansetron15$120$8
Furosemide21$93$4
Tramadol14$81$6
Zolpidem17$47$3
Lorazepam16$33$2

Year by year

Part D prescribing by year
20241,0251386% (63)None$2,938,274
202361312812% (72)None$1,321,566
20222388912% (28)32%$512,934
20212627410% (25)17%$166,730
2020348666% (19)None$263,312
2019361877% (24)None$260,832
20187091096% (40)11%$745,934
201778010211% (83)16%$815,907
20167429212% (88)24%$844,300
20158579815% (129)None$512,295
20144896813% (65)15%$247,398
20136522NoneNone$17,589

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 15 drugs

Part D drugs prescribed in 2023
Xtandi16$192,589$12,037
Eliquis71$52,313$737
Xarelto13$11,880$914
Anastrozole40$1,292$32
Tamoxifen Citrate14$1,000$71
Hydroxyurea31$859$28
Oxycodone20$373$19
Levothyroxine13$294$23
Potassium Chloride12$265$22
Letrozole11$260$24
Tramadol18$228$13
Hydrocodone-Acetaminophen14$179$13
Lorazepam24$136$6
Furosemide24$96$4
Prednisone23$75$3

2022: 5 drugs

Part D drugs prescribed in 2022
Revlimid12$205,575$17,131
Xtandi14$194,217$13,873
Eliquis32$17,424$545
Hydroxyurea13$374$29
Anastrozole12$235$20

2021: 3 drugs

Part D drugs prescribed in 2021
Potassium Chloride18$565$31
Hydroxyurea22$416$19
Prednisone17$73$4

2020: 4 drugs

Part D drugs prescribed in 2020
Xarelto11$9,091$826
Potassium Chloride23$669$29
Levothyroxine19$258$14
Prednisone29$136$5

2019: 9 drugs

Part D drugs prescribed in 2019
Potassium Chloride28$850$30
Anastrozole31$801$26
Letrozole14$388$28
Ondansetron23$271$12
Prednisone32$175$5
Hydrocodone-Acetaminophen11$149$14
Pantoprazole17$112$7
Warfarin11$100$9
Lorazepam17$65$4

2018: 18 drugs

Part D drugs prescribed in 2018
Revlimid18$266,216$14,790
Imbruvica14$163,330$11,666
Zytiga13$140,390$10,799
Tamoxifen Citrate28$1,684$60
Anastrozole67$1,238$18
Hydroxyurea26$992$38
Dexamethasone26$880$34
Ondansetron50$574$11
Diphenoxylate-Atropine31$508$16
Potassium Chloride30$469$16
Hydrocodone-Acetaminophen16$422$26
Prochlorperazine Maleate49$382$8
Prednisone27$352$13
Letrozole20$346$17
Allopurinol12$294$24
Warfarin27$288$11
Lorazepam58$288$5
Hydromorphone13$93$7

2017: 24 drugs

Part D drugs prescribed in 2017
Revlimid16$208,356$13,022
Afinitor12$160,340$13,362
Imbruvica11$124,575$11,325
Xarelto12$4,643$387
Fentanyl31$1,675$54
Tamoxifen Citrate20$1,281$64
Potassium Chloride18$825$46
Anastrozole53$758$14
Letrozole39$743$19
Hydroxyurea23$638$28
Acyclovir13$599$46
Hydromorphone19$571$30
Levofloxacin18$447$25
Ondansetron40$444$11
Diphenoxylate-Atropine22$405$18
Lorazepam77$381$5
Dexamethasone43$377$9
Prochlorperazine Maleate52$369$7
Omeprazole23$364$16
Gabapentin12$298$25
Loperamide12$156$13
Oxycodone13$137$11
Pantoprazole14$106$8
Trazodone14$68$5

2016: 28 drugs

Part D drugs prescribed in 2016
Revlimid16$181,733$11,358
Xalkori11$151,253$13,750
Mekinist12$104,998$8,750
Tafinlar12$95,392$7,949
Neupogen11$15,415$1,401
Xarelto23$8,394$365
Enoxaparin16$6,157$385
Arimidex11$5,330$485
Fentanyl21$1,294$62
Anastrozole43$913$21
Potassium Chloride33$888$27
Levofloxacin12$642$54
Letrozole31$569$18
Hydrocodone-Acetaminophen17$562$33
Hydromorphone25$487$19
Tamoxifen Citrate11$457$42
Gabapentin15$363$24
Hydroxyurea23$354$15
Ondansetron29$340$12
Omeprazole18$338$19
Dexamethasone27$273$10
Acyclovir13$199$15
Lorazepam41$150$4
Prochlorperazine Maleate23$144$6
Zolpidem12$81$7
Pantoprazole13$70$5
Tramadol11$64$6
Furosemide14$20$1

2015: 26 drugs

Part D drugs prescribed in 2015
Zytiga13$101,731$7,825
Xarelto15$4,933$329
Fentanyl24$1,857$77
Potassium Chloride39$1,090$28
Hydrocodone-Acetaminophen41$935$23
Anastrozole35$778$22
Ondansetron29$552$19
Levofloxacin18$501$28
Oxycodone33$498$15
Dexamethasone30$430$14
Metoprolol17$373$22
Levetiracetam11$291$26
Omeprazole18$273$15
Morphine Sulfate13$262$20
Lorazepam43$262$6
Letrozole17$243$14
Gabapentin16$226$14
Hydroxyurea12$192$16
Nystatin11$178$16
Prochlorperazine Maleate31$170$5
Prednisone18$156$9
Zolpidem12$150$12
Furosemide35$108$3
Pantoprazole16$94$6
Famotidine15$85$6
Hydrochlorothiazide20$52$3

2014: 15 drugs

Part D drugs prescribed in 2014
Zytiga15$111,067$7,404
Enoxaparin15$17,324$1,155
Fentanyl22$1,699$77
Levofloxacin17$935$55
Hydrocodone-Acetaminophen34$705$21
Potassium Chloride14$488$35
Anastrozole17$305$18
Dexamethasone19$196$10
Gabapentin17$193$11
Ondansetron15$175$12
Prednisone15$130$9
Prochlorperazine Maleate15$109$7
Lorazepam20$98$5
Furosemide11$51$5
Hydrochlorothiazide11$45$4

2013: 1 drug

Part D drugs prescribed in 2013
Ondansetron11$270$25

Money from drug and device companies

$84 in 2025

Industry payments by year
202534None$84
202425None$79
202336None$99
2022117None$165
202111None$15
202068None$168
201947None$136

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
PfizerIbrance$31
1 payment
  • Education for Ibrance · 2025-07-10 · $31
KerecisKerecis Surgiclose$27
2 payments
  • Meals for Kerecis Surgiclose · 2025-01-23 · $15
  • Meals for Kerecis Surgiclose · 2025-01-06 · $12
AbbvieLupron Depot$26
1 payment
  • Meals for Lupron Depot · 2025-05-20 · $26
See all 4 published payments
Every published payment
PfizerEducation · 2025-07-10Ibrance$31
AbbvieMeals · 2025-05-20Lupron Depot$26
KerecisMeals · 2025-01-23Kerecis Surgiclose$15
KerecisMeals · 2025-01-06Kerecis Surgiclose$12
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)

2024: $79

Payments by company in 2024
Smith+NephewCollagenase Santyl$55
2 payments
  • Meals for Collagenase Santyl · 2024-10-03 · $31
  • Meals for Collagenase Santyl · 2024-09-12 · $23
KerecisKerecis Omega3 Surgiclose$25
2 payments
  • Meals for Kerecis Omega3 Surgiclose · 2024-11-04 · $12
  • Meals for Kerecis Omega3 Surgiclose · 2024-01-11 · $12

2023: $99

Payments by company in 2023
KerecisKerecis Omega3 Surgiclose$53
1 payment
  • Meals for Kerecis Omega3 Surgiclose · 2023-02-14 · $53
PfizerIbrance$25
1 payment
  • Education for Ibrance · 2023-07-27 · $25
AbbvieLupron Depot$21
1 payment
  • Meals for Lupron Depot · 2023-09-22 · $21

2022: $165

Payments by company in 2022
KerecisKerecis Omega3 Surgiclose$165
1 payment
  • Meals for Kerecis Omega3 Surgiclose · 2022-01-06 · $165

2021: $15

Payments by company in 2021
Myriad Genetic LaboratoriesMyrisk$15
1 payment
  • Meals for Myrisk · 2021-10-28 · $15

2020: $168

Payments by company in 2020
SeagenAdcetris$54
2 payments
  • Meals for Adcetris · 2020-03-04 · $30
  • Meals for Padcev · 2020-01-29 · $25
AstraZeneca Pharmaceuticals LPLynparza$36
2 payments
  • Meals for Lynparza · 2020-03-12 · $21
  • Meals for Imfinzi · 2020-01-15 · $15
PfizerXtandi$24
1 payment
  • Meals for Xtandi · 2020-02-24 · $24
Bayer HealthCare PharmaceuticalsNubeqa$22
1 payment
  • Meals for Nubeqa · 2020-02-12 · $22
CelgeneRevlimid$17
1 payment
  • Meals for Revlimid · 2020-01-09 · $17
Foundation MedicineFoundationone$16
1 payment
  • Meals for Foundationone · 2020-01-28 · $16

2019: $136

Payments by company in 2019
IncyteJakafi$52
3 payments
  • Meals for Jakafi · 2019-11-18 · $16
  • Meals for Jakafi · 2019-08-16 · $14
  • Meals for Jakafi · 2019-03-12 · $22
Merck Sharp & DohmeKeytruda$34
2 payments
  • Meals for Keytruda · 2019-09-25 · $19
  • Meals for Keytruda · 2019-07-01 · $15
Seattle GeneticsNone$30
1 payment
  • Meals · 2019-10-07 · $30
PfizerXalkori$20
1 payment
  • Meals for Xalkori · 2019-11-04 · $20

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Merck Sharp & Dohme Corporation · A Phase 3 Randomized, Placebo Controlled Study To Evaluate the Safety and Efficacy of Pemetrexed Platinum Chemotherapy Pembrolizumab Mk 3475 With Or Without Lenvatinib E7080,Mk 7902 As First Line Intervention in Participants With Metastatic Nonsquamous Non Small Cell Lung Cancer Leap 006 · 2020Their institution$57,293
Merck Sharp & Dohme Corporation · A Phase 3 Randomized, Placebo Controlled Study To Evaluate the Safety and Efficacy of Pemetrexed Platinum Chemotherapy Pembrolizumab Mk 3475 With Or Without Lenvatinib E7080,Mk 7902 As First-Line Intervention in Participants With Metastatic Nonsquamous Non Small Cell Lung Cancer Leap-006 · 2021Their institution$56,130
Merck Sharp & Dohme Corporation · A Phase 3 Randomized, Placebo Controlled Study To Evaluate the Safety and Efficacy of Pemetrexed Platinum Chemotherapy Pembrolizumab Mk 3475 With Or Without Lenvatinib E7080,Mk 7902 As First Line Intervention in Participants With Metastatic Nonsquamous Non Small Cell Lung Cancer Leap 006 · 2019Their institution$39,415

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
83.6 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1942456389
Licence
CA A126309California A126309: Current · expires 2026-12-31
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Medical oncology (207RX0202X)
Mailing address
2505 Hospital Dr, Mountain View, CA, 94040
NPI first listed
2008-08-18
NPI last updated
2020-12-04
NPI record certified
2020-12-04

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 700 Mountain Ranch Road, Sanandreas, CA, 95249